Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Conmed (DE:EC8)
FRANKFURT:EC8
Holding DE:EC8?
Track your performance easily
EC8 Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€56.00 - €104.00
Previous Close€72
Volume0.00
Average Volume (3M)15.00
Market Cap
€2.20B
Enterprise Value€3.10B
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$940.81M
Price to Earnings (P/E)―
Beta0.58
Next Earnings
Jan 30, 2025EPS Estimate
€1.15Last Dividend Ex-Date
Sep 16, 2024Dividend Yield1.05%
Share Statistics
EPS (TTM)N/A
Shares Outstanding30,890,853
10 Day Avg. Volume0
30 Day Avg. Volume15
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)2.35
Price to Sales (P/S)1.80
Price to Cash Flow (P/CF)11.30
P/FCF Ratio10.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.41
Enterprise Value/Gross Profit4.59
Enterprise Value/Ebitda11.31
Forecast
1Y Price Target
€77.43Price Target Upside9.05% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering6
Conmed News
PremiumCompany Announcements
CONMED Corporation Reports Strong Q3 2024 Results
PremiumCompany Announcements
Conmed Announces New CEO Amid Strong Q3 Performance
Bulls Say, Bears Say
Bulls Say
Financial PerformanceCNMD's 3Q24 revenue was in line with its preannouncement and its EPS beat consensus, with gross margin up 60 bps and operating margin up 90 bps.
Management And LeadershipThe transition to the new CEO is expected to be seamless as the incoming CEO, Patrick Beyer, has been with the company since 2014 and is already visible with investors.
Product InnovationBioBrace is a bioinductive implant designed to enhance the quality and durability of tendon/ligament repair, with surgeons exploring its use in over 47 different indications.
Bears Say
Manufacturing ImpactHurricane Helene caused CNMD to stop manufacturing at its Largo, FL facility for approximately 24 hours due to employee absences.
Revenue GuidanceManagement lowered their revenue guidance slightly.
Short InterestShort interest on the stock remains high at 8.5% compared to the coverage universe average of ~5%.
---
EC8 FAQ
What was Conmed’s price range in the past 12 months?
Conmed lowest stock price was €56.00 and its highest was €104.00 in the past 12 months.
What is Conmed’s market cap?
Currently, no data Available
When is Conmed’s upcoming earnings report date?
Conmed’s upcoming earnings report date is Jan 30, 2025 which is in 56 days.
How were Conmed’s earnings last quarter?
Conmed released its earnings results on Oct 30, 2024. The company reported €1.001 earnings per share for the quarter, beating the consensus estimate of €0.975 by €0.026.
Is Conmed overvalued?
According to Wall Street analysts Conmed’s price is currently Undervalued.
Does Conmed pay dividends?
Conmed pays a Quarterly dividend of €0.19 which represents an annual dividend yield of 1.05%. See more information on Conmed dividends here
What is Conmed’s EPS estimate?
Conmed’s EPS estimate is €1.15.
How many shares outstanding does Conmed have?
Conmed has 30,890,854 shares outstanding.
What happened to Conmed’s price movement after its last earnings report?
Conmed reported an EPS of €1.001 in its last earnings report, beating expectations of €0.975. Following the earnings report the stock price went up 0.847%.
Which hedge fund is a major shareholder of Conmed?
Among the largest hedge funds holding Conmed’s share is Deerfield Management Company, LP. It holds Conmed’s shares valued at 44M.
---
Conmed Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€77.43 (9.05% Upside)
€77.43 (9.05% Upside)
Blogger Sentiment
Bullish
DE:EC8 Sentiment 100%
Sector Average 71%
Sector Average 71%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-30.04%
12-Months-Change
Fundamentals
Return on Equity
15.24%
Trailing 12-Months
Asset Growth
-0.43%
Trailing 12-Months
Company Description
Conmed
CONMED Corp. operates as a medical technology company, which engages in the development, manufacture and sale of surgical devices and related equipment. It operates through the following geographical segments: United States; Americas excluding the United States; Europe, Middle East, and Africa; and Asia Pacific. Its product lines also include orthopedic surgey and general surgery. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Utica, NY.
---
EC8 Company Deck
---
EC8 Earnings Call
Q3 2024
0:00 / 0:00
---
EC8 Stock 12 Month Forecast
Average Price Target
€77.43
▲(9.05% Upside)
Technical Analysis
Best Analysts Covering EC8
1 Year
1 Year Success Rate
13/24 ratings generated profit
1 Year Average Return
+5.85%
reiterated a buy rating last month
Copying Rick Wise's trades and holding each position for 1 Year would result in 54.17% of your transactions generating a profit, with an average return of +5.85% per trade.
---